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SummAry
our aim was to survey the opinions of italian radiation and EnT oncologists regarding the role of postoperative radiotherapy (PrT) and the 
appropriate dose to be given to patients with remnant larynx (rl) after open partial laryngectomy (oPl). The radio-oncologists (ros) of 
the italian radiation-oncologist Association (Airo) and the EnTs of the head-neck oncology Society (AioCC-ihnS) were contacted 
through a Surveymonkey online interface questionnaire. There were 148 usable responses. The majority of ros recommended PrT in the 
case of positive/close margins (r
(+)
/r
close
) or in the case of initial involvement of thyroid cartilage (pT3
tci
). in the same cases, EnTs prefer 
a “watch and wait” policy (w&w). Both disciplines recommended w&w in the case of negative margins (r
(-)
). Finally, the majority of ros 
recommended irradiating rl with 62-66 gy in r
(+)
, with 56-66 gy (61.4%) in r
close
 and with 56-60 gy (34%) in pT3
tci
. in Conclusion, oPl 
raises new considerations about PrT.
KEy wordS: Larynx • Postoperative radiotherapy • Conservative laryngectomy • Partial laryngectomy • Head and neck cancer
riASSunTo
L’introduzione nella pratica clinica della Chirugia conservativa nei carcinomi laringei e della Radioterapia ad intensità modulata (IMRT) 
conformabile ai volumi a rischio pone nuove problematiche alla comunità scientifica relativamente alle dosi e volumi da radiotrattare ed 
alle tolleranze non note del residuo laringeo. Il principale scopo di questa “Survey” è di raccogliere le opinioni di ORL e radiooncologi 
italiani relativamente al ruolo della radioterapia postoperatoria (PRT) e l’entità di dose da erogare al residuo laringeo (RL) dopo chirur-
gia conservativa open-neck (OPL). Un questionario online (attraverso l’interfaccia Surveymonkey®) è stato inviato ai radiooncologi della 
Associazione Italiana di Radiooncologia (AIRO) ed agli ORL della Associazione Italiana di Oncologia cervicocefalica (AIOCC-IHNS).Le 
risposte utilizzabili sono state 148. La maggioranza dei Radiooncologi ha raccomandato la PRT nei casi di margini positivi o close (R
(+)
/
R
close
) o nel caso di coinvolgimento iniziale della cartilagine tiroide (pT3
tci
). Negli stessi casi gli ORL preferivano un atteggiamento di vigile 
attesa (“watch and wait”) (w&w). Entrambi gli specialisti raccomandavano w&w nel caso di margini negativi (R
(-)
). Infine la maggioranza 
di Radiooncologi raccomandava l’irradiazione del residuo laringeo a dosi di 62-66Gy nel caso di R
(+)
, a dosi di 56-66 Gy (61,4%) nel 
caso di R
close
 e di 56-60 Gy (34%) nei pT3
tci
. In conclusione l’introduzione nella pratica clinica della laringectomia conservativa open-neck 
solleva nuove riflessioni relativamente al ruolo della Radioterapia postoperatoria per quanto riguarda le indicazioni, le dosi da utilizzare 
sul residuo laringeo (se giudicato a rischi di recidiva) ed i volumi da radiotrattare.  
PArolE ChiAvE: Laringe • Radioterapia postoperatoria • Laringectomia conservativa • Laringectomia parziale • Tumori testa-collo
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Introduction
The optimal treatment strategy for squamous cell car-
cinoma (SCC) of the larynx is still a matter of debate. 
Radiotherapy (RT), with or without chemotherapy (CT), 
open partial laryngectomy (OPL) and endoscopic resec-
tion are established options for functional preservation 
treatment 1 2. Various factors influence the choice of the 
treatment strategy: primary tumour site, stage and expect-
ed results, as well as the expertise of the multidisciplinary 
team, availability of the service and rehabilitation facili-
ties, along with the patient’s decision 3.
The early clinical stages of supraglottic and glottic cancer 
that do not require total laryngectomy (most T1-2 N0 cases) 1 
are usually considered for either conservative surgery (endo-
scopic resection, OPL with/without neck dissection) or RT. 
Single-modality treatment with surgery or RT is generally 
recommended for early-stage disease (stage I or stage II) in 
order to preserve the other choice in case of recurrence 1.
Resectable, advanced-stage glottic and supraglottic pri-
maries are usually managed with a combined modality 
approach 4-6. If treated with primary surgery, total laryn-
gectomy is typically required 1. However, some authors 7-11 
recommend an OPL approach even in selected advanced 
cancers with or without postoperative radiotherapy (PRT). 
These selected cases often need to resort to PRT, which 
could add additional risk of late laryngeal toxicity, jeop-
ardizing the expected functional outcome 3 9 12.
Furthermore, early-stage laryngeal cancers (T1-2 N0) can 
be clinically under-staged (16.3%) 7 and postoperative ad-
verse pathologic findings might place these cases into a 
pathologically advanced stage (i.e. early invasion into the 
thyroid cartilage 13 (pT3
tci
), metastatic adenopathies (pN+) 
with or without extra-capsular extension (ECE) or posi-
tive residual margins (R
(+)
) 14.
In these situations, the optimal treatment option, whether 
to transform a conservative approach into immediate total 
laryngectomy (ITL), or to preserve the organ function by 
adopting PRT – CT or a close “watch and wait” policy 
(w&w), is unclear. At present, the most common Head 
and Neck Cancer (HNC) guideline 1 leaves wide freedom 
of choice among possible therapeutic options (re-exci-
sion, RT, RT-CT), and the recommendations regarding the 
choice of clinical volumes to be targeted and the respec-
tive radiation dose to be released are vague.
The aim of this study was to evaluate the opinion of Ital-
ian Radiation Oncologists (ROs) and ENTs on PRT ± CT 
when clinical early-intermediate stage (cT1-T2 or limited 
T3 conservatively operable with cN0) glottic and supra-
glottic cancer are pathologically upgraded in consequence 
of their unfavourable histopathologic prognostic factors 
(e.g. pT3
tci
, or R
(+)
).
In particular, the following were investigated:
•	 suggestions	 of	 HNC	 specialistsregarding	 the	 treat-
ment of RL in the presence of the following unfa-
vourable histopathologic prognostic factors: R
(+) 
(mar-
gins < 1 mm) or R
close
 (margins 1-5 mm) 15 or pT3
tci
;
•	 when	neck	volumes	without	metastatic	 adenopathies	
need to be targeted in circumstances in which the RL 
needs to be irradiated;
•	 the	dose	of	radiation	that	ROs	recommend	for	the	RL,	
considering the risk of sequelae are not fully known.
Materials and methods
A multidisciplinary -review board (ROs and ENTs:) ap-
proved the online questionnaire that was sent to RO mem-
bers of the Italian Association of Radiation Oncology 
AIRO head and neck workgroup (161 ROs), and the ENT 
members of the Italian Head and Neck Oncologic Society 
(AIOCC-IHNS) (101 ENTs). The questionnaire focused 
on the behaviour of different disciplinary specialists fac-
ing glottic and supraglottic clinically early-intermediate 
staged head and neck cancer (T1-T2-and conservatively 
operable T3 with cN0) after OPLs, when the histological 
prognostic factors placed these cases into more advanced 
stages.
The survey was prepared on the SurveyMonkey online in-
terface (www.SurveyMonkey.com). Personalized e-mail 
invitations with direct links to the survey were sent on 9 
January 2012. No compensation was offered to respond-
ents. Responses were collected over a 2-month period 
(until 9 March 2012).
Survey questions
The survey contained demographic information and 12 
multiple-choice questions. The first five questions (Ta-
ble  I) regarded respondents’ clinical setting and experi-
ence. Questions 6-9 (Figs. 1-4) focused on the therapeuti-
cal approach to RL after OPLs in the case of unfavourable 
prognostic factors regarding T-site (N-site prognostic 
factors were not considered in these questions). Ques-
tions 10-11 (Fig. 5) focused on radiation target volumes 
(RL ± lymph-nodal areas) in those cases in which the N-
site prognostic factors are considered uncertain in the hy-
potheses in which the RL needed to be irradiated. The last 
question (Fig. 6, Table II)was reserved for ROs in order to 
know the radiation dose level recommended for RL in the 
case of R
(+)
 or R
close
 or R
(-)
 or pT3
tci
.
Analytical overview
Dataset analysis was clusterized into ENTs and ROs for 
direct comparison.
Statistical analysis
Descriptive statistics, Fisher’s exact tests (Fisher’s P
(two tailed)
) 
or chi-square tests (P
Chi-square
) were performed using Win-
pepi software, where appropriate  16. When a significant 
chi-square association was found, adjusted residuals were 
calculated to indentify those cells that contributed most 
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to the chi-square. Using the contingency table of Fisher’s 
exact tests, the examined specific endpoint (e.g. PRT) was 
tested against the sum of remaining endpoints (i.e. ITL 
and w&w policy), considered together with the alternative 
hypothesis (see Figs. 1-4). Frequencies were automatical-
ly calculated by Survey-Monkey.
Results
A total of 154 of 262 questionnaires sent (161 to ROs and 
101 to ENTs) were filled in (58.8% response rate). Of the 
154 respondents, 6 were excluded because they answered 
only the first three questions, which were concerned only 
with institutional demographics. Consequently, 148 us-
able responses (56.4%) were included in the final analy-
sis: 109/161 ROs (respondent RO
(%)
 = 67.7%) and 39/101 
ENTs (respondent ENT
(%)
 = 38.6%).
Respondents’ clinical setting and experience (Table I)
Respondents represented a variety of working settings: 
primarily exploiting activity in non-academic hospitals 
(58%), academic hospitals (25%), and private institutions 
(17.0%). Most respondents (87.2%) had a HNC-board 
(HNCB) in their institution. Particularly, 65.1% of re-
spondents evaluated all patients before any specific treat-
ment within their HNCB, while 34.9% evaluated only 
selected patients (inoperable patients selected by ENTs 
or patients who did not meet institutional guidelines). 
Among those who answered the questionnaire, 31/39 
ENTs (79.5%) vs. 56/109 ROs (51.4%) had more than 10 
years’ experience working with HNC patients (Fisher’s 
P
(two tailed)
 = 0.002) (see details in Table I, Question 1). Con-
versely, more ROs than ENTs worked in institutions with 
less than 50 HNCPs per year (see details in Table I; Ques-
Table I. Respondents’ clinical setting and experience.
1. How many years have you been working with Head and Neck Cancer Patients (HNCPs)?
Answer RO N (%)
ENT 
N (%)
Ratio 
RO%/ENT%
p*
0.001
a) Less than 5 years 18 (16.5%) 1 (2.5%) 6.44 0.025§
b) 6-10 years 35 (32.1%) 7 (17.9%) 1.78 0.09§
c) 11-20 years 36 (33.0%) 12 (30.8%) 1.073 0.79§
d) More than 20 years 20 (18.3%) 19 (48.7%) 0.37 0.000§
2. How many HNCPs are taken care of per year in your institution?
Answer RO N (%)
ENT 
N (%)
Ratio 
RO%/ENT%
p*
0.03
a) Less than 50 39 (35.8%) 5 (13.6%) 2.7 0.009†
b) From 51-100 37 (33.9%) 17 (44.7%) 0.76 0.235†
c) From 101-150 19 (17.4%) 7 (18.4%) 0.95 0.890†
d) More than 150 14 (12.8%) 9 (23.7%) 0.54 0.113†
3. How many HNCPs submitted to conservative laryngectomy do you see per year?
Answer RO N (%)
ENT 
N (%)
Ratio 
RO%/ENT%
p*
0.22
a) Less than 5 25 (22.9%) 4 (10.2%) 2.236
a) 5-10 39 (35.8%) 13 (33.3%) 1.073
b) 11-20 26 (23.8%) 11 (28.2%) 0.846
c) More than 20 19 (17,4%) 11 (28.1%) 0.618
4. Do you have a head and neck cancer board (HNCB) in your institution?
Answer RO N (%)
ENT 
N (%)
Ratio 
RO%/ENT%
p*
0.20
a) Yes 93 (85.3%) 36 (92.3%)
b) No 16 (14.7%) 3 (7.7%)
5. Does your HNCB evaluate:
Answer
RO 
N (%)
ENT 
N (%)
Ratio 
RO%/ENT%
p*
0.33
a) Selected patients (inoperable patients selected 
    by ENT)? 27 (29.03%) 6 (16.67%) 1.742
b) All patients before any specific treatment? 58 (62.37%) 26 (72.22%) 0.864
c) Other? (please specify) 8 (8.6%) 4 (11.11%) 0.774
* Chi-square tests; † Adjusted residuals (cell-by-cell analyses).
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tion 2). Finally, considering the num-
bers of HNCPs submitted to OPL per 
year seen for each specialist (Table I, 
Question 3) there was no statistically 
difference (P
Chi-square
 = 0.22) between 
the two specialist groups.
When does the remnant larynx need 
further treatment? (Figs. 1-4)
The clinical scenario of T-site prog-
nostic factors (with no consideration 
of lymph-nodal prognostic factors) 
is shown in Figs. 1-4. In the case of 
R
(+)
 after OPL (Fig.  1, Question 6), 
the majority of specialists recom-
mended RT, with no significant sta-
tistically difference between the two 
specialist groups (p  =  0.60). How-
ever, ROs more frequently would add 
CT to RT (RO
(%)
/ENT
(%)
 = 3.27). In 
the case of R
close
 (Fig.  2, Question 
7), the opinions between the two 
specialist groups were statistically 
different (p = 0.000047) since more 
ROs recommended RT ± CT, while a 
higher ENT
(%)
 recommended a w&w 
policy (p = 0.000029). In the case of 
R
(-) 
disease (Fig.  3, Question 8), the 
majority of both specialist groups 
would recommend a w&w policy. 
Finally, in the case of pT3
tci
 (Fig. 4, 
Question 9) a higher RO
(%)
 advised 
RT ± CT (p = 1.3 E-7), while a high-
er ENT
(%)
 advised a w&w approach 
(p = 0.000028).
When do neck volumes need to be tar-
geted? (Fig. 5)
Two scenarios in which the RL need-
ed to be irradiated (considering T-
site unfavourable prognostic factors) 
were provided for: first in which the 
neck was not dissected with clini-
cal negative metastatic lymph-nodes 
(cNo) and second in which elec-
tive neck dissections did not reveal 
metastatic lymph nodes (pNo). In 
the former scenario, 64.7% of ROs 
recommended irradiating both cNo 
areas and RL, while in the latter the 
majority of RO
 
recommended ir-
radiating only the RL. The attitude 
of ENTs was not statistically differ-
ent for the two scenarios (p = 0.132) 
(Fig. 5).
Fig. 1. Which course of action do you recommend for the RL in the case of R(+) (margins < 1 mm) 
(Question 6).
Fig. 2. Which course of action do you recommend for the RL in the case of R
close
 (margins 1-5 mm) 
(Question 7).
Fig. 3. Which course of action do you recommend for the RL in the case of R(-) (margins > 5 mm) 
(Question 8).
Fig. 4. Which course of action do you recommend for the RL in the case of R(-) but pT3
tci
 (Question 9).
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Which doses are more frequently 
recommended on remnant lar-
ynx? (Fig. 6, Table II)
Fig.  6 shows the dosage recom-
mended by 103/109 RO respond-
ents.
Discussion
This study attempted to compare 
the points of view of ROs and 
ENTs concerning a relatively 
new question on the postoperative 
approach to OPL. To our knowl-
edge, this is the first nationwide 
survey on this topic. Data from 
literature are only retrospective 
and thy come from mono- or 
bi-institutional studies  3  8-12  17  18 
(Table  III). The most reported 
late toxicities are severe oedema 
condritis (7%)  12, radionecrosis 
(5.5%)  12, aspiration and pneu-
monia (29.4%) 11 and toxic death 
(4%) 17 (Table III).
Indeed, the modern approach of 
OPL has reached prominence in 
the clinical field only in recent 
years, and different conservative 
laryngectomy procedures have 
been adopted for different exten-
sions of tumour  19. Recently, a 
systematic review of retrospec-
tive mono-institutional studies  20 
in the English language literature 
has given more credence to the 
oncologic efficacy and reliable 
function preservation of these 
procedures considering the high 
local control (90%) reported in 
over 5000 patients and the high 
larynx preservation rate (91%) 
in over 3000 patients. However, 
Table II. Which radiation dose do you recommend to the laryngeal remnant when radiotherapy is advisable or when the patient refuses immediate total 
laryngectomy? (Question 12) (see also Fig. 6).
Answer Options Not recommended < 56 Gy
56-60 
Gy
62-66 
Gy
> 66 
Gy Response Count
- R+ (margins < 1 mm) 4 1 15 54 29 103
- R-close (margins 1- 5 mm) 17 11 30 32 11 101
- Ro (margins > 5 mm) 70 6 19 5 1 101
- Ro (in patients with cartilage invasion- p T3) 27 15 34 20 4 100
answered question 103
skipped question 6
Fig. 5. cNo – when you are obliged to irradiate the RL for the presence of negative prognostic factors in 
the tumour site, do you think that in this case the cNo areas should you be irradiated with RL? (Question 10). 
pNo – when you are obliged to irradiate the RL for the presence of negative prognostic factors in the tumour 
site, do you think that in this case the pNo areas should you be irradiated with RL? (Question 11).
Fig. 6. Which radiation dose do you recommend for the laryngeal remnant when radiotherapy is advisable 
or when the patient refuses immediate total laryngectomy? (doses are expressed in Dose equivalent 2 Gy/
fr.) (Question 12).
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Thomas 20 reported that approximately 22% of the patients 
(1151 of 5196) did not have a T-stage available. Thus, 
blurred stage selections, surgical technique and postop-
erative care represent challenges that nowadays limit OPL 
to specific expertise to ensure reproducible results.
Specifically, this new scenario generated some concerns 
among ROs because of the limited amount of data on 
this subject  3  8  9  12 (Table  III), and in particular concern-
ing the radiation tolerance of RL after OPL. Nevertheless, 
information concerning the risk of toxicity is lacking in 
a comprehensive evaluation of the risk-benefit balance, 
while PRT is suggested by some Authors to improve local 
control 7.
At the same time, the possibility to reserve a rescue to-
tal (or sometimes partial) laryngectomy without survival 
detriment can drive physicians’ opinion towards a w&w 
policy when unpredicted, unfavourable prognostic factors 
are found in the pathological specimen 21. Indeed, in our 
survey a higher ENT
(%)
 advised a w&w policy in case of 
R
close
 or pT3
tci
 (Figs. 2, 4).
In addition, the recent introduction in radiation oncol-
ogy practice of modern intensity modulated radiotherapy 
(IMRT), allowing for conformal RT adaptation to irregu-
lar neck shape helps to spare organ function and critical 
tissues (e.g. resected larynx) from high radiation dosages. 
This opportunity is raising interest for PRT 22.
This expectation could explain the higher percentage 
of ROs’ responses (67.8%) vs. ENTs (38.6%) (RO(%)/
ENT(%)  =  1.76), tending to testify a higher concern 
among ROs.
With regards to the Italian-HNC specialists’ attitude to-
wards the T-site prognostic factors, the results describe 
substantial agreement both in not using PRT in R
(-)
 pa-
tients and in using it in R
(+)
. Their opinions diverge in the 
case of R
close
 and pT3
tci
 (Figs. 2, 4). Indeed, in these cases 
ROs advise RT more frequently. In contrast, ENTs more 
frequently suggest a w&w policy in R
close
 and pT3
tci
 cases.
However, in the case of R
(+)
, the majority of ROs recom-
mended adding CT to RT, while the majority of ENTs did 
not recommend it (Fig. 1, Question 6). The discussion of 
Table III. Tissue tolerance in the case of open neck conservative laryngectomy plus postoperative radiotherapy.
Author Pts Surgery RT technique Remnant larynx average dose Neck dose Late toxicity Interrupted PRT Severe complications Permanent sequel Toxic death
Dose evaluated as at 
risk of complication
Robbins 1988 17 25 Horizontal supraglottic laryngectomy 2D-RT Not reported Not reported 8/25 (32%) Prolonged feeding tube (2/25; 8%)Aspiration with pneumonia (4/25; 16%) Tracheostomy (2/25; 8%)
Pneumonia  
(1/25; 4%) NR
Spaulding CA 
1989 10 23
Standard supraglottic laryngectomy
Extended supraglottic laryngectomy
Extended vertical laryngectomy
2D-RT 50-61 Gy 50-61 Gy Lymphoedema neckArytenoid oedema resolved after several months Laryngectomy (1/23) None NR
Lee 1990 8 50  (+10 not irradiated) Horizontal supraglottic laryngectomy 2D-RT 55 Gy 63 Gy
NA (mixed to non 
irradiated patients)
Interruption for  
arytenoid swelling  
(1/60)
Prolonged feeding gastrostomies (7/50; -14%)
Pneumonia 3%
Laryngectomy (3/50) (6%)
Tracheostomy 2% 3 death NR
Steiniger 1997 11
17
(vs. 12 without 
postoperative 
radiotherapy)
Horizontal supraglottic laryngectomy
1 extended to the tongue base HSGL
2D-RT
4-6 MV
LINAC
60Co beam
59.30 Gy
(50.4-66 Gy)
45.10 Gy 
(40-50 Gy) 1 patient not compliant
The average time of decannulation 14.3 w 
(vs. 6.8 w no RT; p = 0.18
To develop adequate oral intake 34.8 w 
(vs. 7.5 w of no RT)
Acute upper air respiratory in 5 (29.4%) pts 
(vs. = 0; p < 0.05)
Pneumonia in 7 patients (29.4%) vs. 1/12 
no RT (8.3%) (P = 0.18)
Temporary feeding tube n = 6 (35.2%) 
(vs. 0/12) p = .026
4 permanent tracheostomy (23.5%) 
vs. 0/12 no RT (p = 0.10)
1 fatal respiratory 
arrest NR
Laccourreye 2000 12 90 Standard supraglottic laryngectomySupracricoid partial laryngectomy
2D RT
60Co beam
51.2 Gy 
(25-71)
50.6 Gy 
(22-70) 15/90 (16.6%) (5 = 5.5%) (40 Gy)
Laryngeal radionecrosis 5/90 (5.5%)
Laryngeal stenosis 4/90 (4.4%)
Aspiration pneumonia 3/90 (3.3%)
Skin necrosis (3.3%)
Oesophageal inlet stenosis 2/90 (2.2%)
Gastrostomy 3/90 (3%)
Tracheostomy (1/90) (1.1%) 3 (3.3%)
60 Gy (univariate 
p = 0.014)
Spriano 2000 14 56 Standard supraglottic laryngectomyExtended supraglottic laryngectomy
2D RT-60Co beam
2D RT- 6MV LINAC 50 Gy 46 Gy 30/56 (54%)
Severe oedema/chondritis (7%)
Laryngeal necrosis (1%)
Persistent aspiration (9%)
Fistula (2%)
Tracheostomy (1/56) (2%) None > 50 Gy (HR = 2.2)
Oksuz 2008 18 79 Horizontal supraglottic laryngectomyExtended supraglottic laryngectomy 2D RT-60Cobalt beam
50 Gy 
(48-70 Gy) 50 Gy 22/79 (27.8%)  
Laryngeal oedema (17/79-21.5%)
Aspiration/dysphagia (6/79-7.5%)
Definitive laryngectomy (1/79-1.3%)
Definitive tracheostomy (3/79 -3.7%) None NA
Garibaldi 2009  3 36
Horizontal supraglottic laryngectomy
Extended supraglottic laryngectomy
Fronto-lateral laryngectomy
Other
2D RT- 6MV LINAC
3DCRT
59.5 Gy 
(45-70.2)
50.4 Gy 
(39.6-55.8) 21/32 (65.6%)
Temporary feeding tube (3.1%)
Temporary tracheostomy (3.1%)
Severe neck induration (3.1%)
Whispered speech (1%)
Definitive tracheostomy (3.1%)
Tracheostomy (1/32) (3.2%) None 54.9 Gy (estimated) (50.4-55.8)
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this item brought about an interesting question among the 
Authors of the present study: does the positive margin of 
an early-stage tumour in a conservative scenario have the 
same negative prognostic significance of the positive mar-
gin in an advanced-stage tumour in a non-conservative 
scenario? It is possible that the majority of ENTs did not 
add CT to RT because they attributed a less negative prog-
nostic meaning to early-stage positive margins.
Regarding radiation volumes (Questions 10 and 11), com-
ments were gathered from both specialist groups’ ques-
tionnaires (ROs = 9; ENTs = 7) concerning the fact that 
the questions did not specify the T-stage and/or the T-site 
(glottis or supra-glottis) contexts. With these limits in 
mind, the evaluation of responses to two questions per-
mit us to conclude that in the case of cNo both special-
ist groups would recommend RT both on the undissected 
neck and the RL whenever the latter needed to be irradi-
ated. This trend is reversed in the case of pNo where only 
RL irradiation is more often recommended (Fig. 5, Ques-
tions 10-11).
Finally, the questionnaire asked ROs to specify the ad-
vised radiation dose on the RL. As shown in Fig.  1, a 
62-66 Gy dosage was more frequently recommended in 
R
(+) 
patients, and 56-60 Gy in the case of pT3
tci
. The rec-
ommendations were substantially equally split between 
56-60 Gy (29.7%) and 62-66 Gy (31.7%) in the case of 
R
close
. However, the trend was to advise doses higher than 
those usually recommended  23  24. Actually, authors from 
MDACC, Texas  23 and Ann-Arbor Hospital, Michigan  24 
suggest limiting tolerance doses to RL after a horizon-
tal supraglottic laryngectomy up to 55.8 Gy to conserve 
larynx function. Garden 23 recommend treating the larynx 
to 60 Gy in the rare cases in which positive margins are 
encountered, and Laccourreye 12 does not recommend ra-
diation on RL with negative margins as he reported chon-
droradionecrosis and/or laryngeal stenosis in 6 negative-
margin-T3 patients in his retrospective study. Thus, the 
pros and cons of PRT need to be studied further.
To our knowledge, only 3 studies 3 9 12 have provided a re-
lationship between delivered dose to RL and the risk of 
Table III. Tissue tolerance in the case of open neck conservative laryngectomy plus postoperative radiotherapy.
Author Pts Surgery RT technique Remnant larynx average dose Neck dose Late toxicity Interrupted PRT Severe complications Permanent sequel Toxic death
Dose evaluated as at 
risk of complication
Robbins 1988 17 25 Horizontal supraglottic laryngectomy 2D-RT Not reported Not reported 8/25 (32%) Prolonged feeding tube (2/25; 8%)Aspiration with pneumonia (4/25; 16%) Tracheostomy (2/25; 8%)
Pneumonia  
(1/25; 4%) NR
Spaulding CA 
1989 10 23
Standard supraglottic laryngectomy
Extended supraglottic laryngectomy
Extended vertical laryngectomy
2D-RT 50-61 Gy 50-61 Gy Lymphoedema neckArytenoid oedema resolved after several months Laryngectomy (1/23) None NR
Lee 1990 8 50  (+10 not irradiated) Horizontal supraglottic laryngectomy 2D-RT 55 Gy 63 Gy
NA (mixed to non 
irradiated patients)
Interruption for  
arytenoid swelling  
(1/60)
Prolonged feeding gastrostomies (7/50; -14%)
Pneumonia 3%
Laryngectomy (3/50) (6%)
Tracheostomy 2% 3 death NR
Steiniger 1997 11
17
(vs. 12 without 
postoperative 
radiotherapy)
Horizontal supraglottic laryngectomy
1 extended to the tongue base HSGL
2D-RT
4-6 MV
LINAC
60Co beam
59.30 Gy
(50.4-66 Gy)
45.10 Gy 
(40-50 Gy) 1 patient not compliant
The average time of decannulation 14.3 w 
(vs. 6.8 w no RT; p = 0.18
To develop adequate oral intake 34.8 w 
(vs. 7.5 w of no RT)
Acute upper air respiratory in 5 (29.4%) pts 
(vs. = 0; p < 0.05)
Pneumonia in 7 patients (29.4%) vs. 1/12 
no RT (8.3%) (P = 0.18)
Temporary feeding tube n = 6 (35.2%) 
(vs. 0/12) p = .026
4 permanent tracheostomy (23.5%) 
vs. 0/12 no RT (p = 0.10)
1 fatal respiratory 
arrest NR
Laccourreye 2000 12 90 Standard supraglottic laryngectomySupracricoid partial laryngectomy
2D RT
60Co beam
51.2 Gy 
(25-71)
50.6 Gy 
(22-70) 15/90 (16.6%) (5 = 5.5%) (40 Gy)
Laryngeal radionecrosis 5/90 (5.5%)
Laryngeal stenosis 4/90 (4.4%)
Aspiration pneumonia 3/90 (3.3%)
Skin necrosis (3.3%)
Oesophageal inlet stenosis 2/90 (2.2%)
Gastrostomy 3/90 (3%)
Tracheostomy (1/90) (1.1%) 3 (3.3%)
60 Gy (univariate 
p = 0.014)
Spriano 2000 14 56 Standard supraglottic laryngectomyExtended supraglottic laryngectomy
2D RT-60Co beam
2D RT- 6MV LINAC 50 Gy 46 Gy 30/56 (54%)
Severe oedema/chondritis (7%)
Laryngeal necrosis (1%)
Persistent aspiration (9%)
Fistula (2%)
Tracheostomy (1/56) (2%) None > 50 Gy (HR = 2.2)
Oksuz 2008 18 79 Horizontal supraglottic laryngectomyExtended supraglottic laryngectomy 2D RT-60Cobalt beam
50 Gy 
(48-70 Gy) 50 Gy 22/79 (27.8%)  
Laryngeal oedema (17/79-21.5%)
Aspiration/dysphagia (6/79-7.5%)
Definitive laryngectomy (1/79-1.3%)
Definitive tracheostomy (3/79 -3.7%) None NA
Garibaldi 2009  3 36
Horizontal supraglottic laryngectomy
Extended supraglottic laryngectomy
Fronto-lateral laryngectomy
Other
2D RT- 6MV LINAC
3DCRT
59.5 Gy 
(45-70.2)
50.4 Gy 
(39.6-55.8) 21/32 (65.6%)
Temporary feeding tube (3.1%)
Temporary tracheostomy (3.1%)
Severe neck induration (3.1%)
Whispered speech (1%)
Definitive tracheostomy (3.1%)
Tracheostomy (1/32) (3.2%) None 54.9 Gy (estimated) (50.4-55.8)
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radiation-induced complications (Table II): their estima-
tion ranges from 50 Gy to 60 Gy. However, the substan-
tial pitfalls of these studies are that they are retrospective, 
mono/double-institutional and heterogeneous in evalua-
tion methodology.
Our study has some limitations since it is an opinion-
based survey with mainly motivated respondents, and 
thus it might not reflect actual clinical practice in Italy.
In addition, the need to keep the questionnaire short in 
order to encourage respondents to fill it in limited the 
clarity of some questions. As mentioned above, it would 
have been useful to specify: the primary site (glottic or 
supraglottic), to define margins to be considered disease-
free based on the relative anatomical site (either glottis 25 
or supraglottic 26), and to better define the clinical stage 
in each scenario. Furthermore, the survey was limited to 
OPL and did not consider trans-oral approaches. Never-
theless, to our knowledge, this study is the first to gather 
the opinions of ROs and ENTs from two national scien-
tific societies (AIRO and AIOCC-IHNS) concerning RT 
indications after OPL. Taking into account the modern 
concepts of function-sparing laryngectomy and latest 
radiation technology, this topic will probably be increas-
ingly important in institutional HNCB multidisciplinary 
debates.
Conclusions
This Italian survey of 109 ROs and 39 ENTs shows that:
•	 both	specialist	groups	would	recommend	PRT	in	the	
case of R
(+)
 disease, but most ROs would add chemo-
therapy. Most ROs (52.4%) recommend 62-66 Gy;
•	 in	the	case	of	R
close
 or pT3
tci
, while ENTs prefer a w&w 
policy, the majority of ROs prefer RT with a dose of 
56-60 Gy (29.7%) – 62-66 Gy (31.7%) in the case of 
R
close
 or 56-60 Gy (34%) in the case of pT3
tci
;
•	 neither	 specialist	groups	would	 recommend	PRT	 in	
the case of R
(-)
 disease, but both would recommend 
RT for undissected cN0 neck when RT is indicated 
for the RL.
The issues dealt with in this survey call for renewed at-
tention and prospective studies, considering the intro-
duction of the unique combination of function-sparing 
laryngectomy concepts in clinical practice and the latest 
IMRT-techniques allowing for selective target volume 
irradiation.
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